Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.
2.

Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis.

Natarajan SK, Ogilvy CS, Hopkins LN, Siddiqui AH, Levy EI.

J Neurointerv Surg. 2010 Jun;2(2):104-9. doi: 10.1136/jnis.2009.001875.

PMID:
21990588
3.

Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.

Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG.

Stroke. 2006 Oct;37(10):2562-6. Epub 2006 Sep 7.

5.

Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience.

de Rochemont Rdu M, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J.

Radiology. 2004 Apr;231(1):45-9.

PMID:
15068940
6.

Proximal left anterior descending coronary artery revascularization with drug-eluting stents.

Guardado JH, Moreno R, Costa J, Perez-Viscayno MJ, Segura L, Alfonso F, Hernández R, Escaned J, Bañuelos C, Macaya C.

Arq Bras Cardiol. 2007 Feb;88(2):159-66. English, Portuguese.

7.

One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.

Chevalier B, Moulichon R, Teiger E, Brunel P, Metzger JP, Pansieri M, Carrie D, Stoll HP, Wittebols K, Spaulding C, Fajadet J; Cristal Investigators.

J Interv Cardiol. 2012 Dec;25(6):586-95. doi: 10.1111/j.1540-8183.2012.00769.x. Epub 2012 Sep 20.

PMID:
22994863
8.

Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.

Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB.

Circulation. 2004 Mar 16;109(10):1244-9. Epub 2004 Feb 23.

9.

Solving the Issue of Restenosis After Stenting of Intracranial Stenoses: Experience with Two Thin-Strut Drug-Eluting Stents (DES)-Taxus Element™ and Resolute Integrity™.

Kurre W, Aguilar-Pérez M, Fischer S, Arnold G, Schmid E, Bäzner H, Henkes H.

Cardiovasc Intervent Radiol. 2015 Jun;38(3):583-91. doi: 10.1007/s00270-014-1001-3. Epub 2014 Oct 24.

PMID:
25342135
10.

[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].

Chen JL, Yang YJ, Qiao SB, Yao M, Qin XW, Xu B, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Li JJ, Gao RL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Apr;35(4):305-7. Chinese.

PMID:
17711652
11.

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP; REALITY Trial Investigators.

JAMA. 2006 Feb 22;295(8):895-904.

PMID:
16493102
12.

Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.

Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, Janjua N, Alkawi A.

Neurosurgery. 2006 Nov;59(5):1044-51; discussion 1051.

PMID:
17143239
13.

A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.

Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ.

Neurosurgery. 2007 Aug;61(2):236-42; discussion 242-3.

PMID:
17762735
14.

Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.

Vassiliades TA Jr, Douglas JS, Morris DC, Block PC, Ghazzal Z, Rab ST, Cates CU.

J Thorac Cardiovasc Surg. 2006 May;131(5):956-62. Epub 2006 Apr 27.

15.

Primary stenting of intracranial atherosclerotic stenoses.

Straube T, Stingele R, Jansen O.

Cardiovasc Intervent Radiol. 2005 May-Jun;28(3):289-95.

PMID:
15789258
16.

Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency.

Vajda Z, Aguilar M, Göhringer T, Horváth-Rizea D, Bäzner H, Henkes H.

Clin Neuroradiol. 2012 Sep;22(3):227-33. doi: 10.1007/s00062-011-0125-y. Epub 2012 Jan 18.

17.

Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(12):1-97. Epub 2006 Apr 1.

18.

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME; TAXUS VI Investigators.

Circulation. 2005 Nov 22;112(21):3306-13. Epub 2005 Nov 14.

19.

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISAR-DESIRE Study Investigators.

JAMA. 2005 Jan 12;293(2):165-71.

PMID:
15644543
20.

Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses.

Steinfort B, Ng PP, Faulder K, Harrington T, Grinnell V, Sorby W, Morgan MK.

J Neurosurg. 2007 Feb;106(2):222-5.

PMID:
17410703

Supplemental Content

Support Center